|
|
Doron Merkler, Edit Horvath, Wolfgang Bruck, Rolf M. Zinkernagel, Juan Carlos del la Torre, Daniel D. Pinschewer
J Clin Invest. 2006;
116(5):1254
doi:10.1172/JCI27372
Abstract |
Full text
| PDF
| Supplemental material

A
utoimmune diseases are often precipitated by viral infections. Yet our current understanding fails to explain how viruses trigger organ-specific autoimmunity despite thymic tolerance extending to many nonlymphohematopoietic self antigens. Additionally, a key epidemiological finding needs to be explained: In genetically susceptible individuals, early childhood infections seem to predispose them to multiple sclerosis (MS) or type 1 diabetes years or even decades before clinical onset. In the present work, we show that the innate immune system of neonatal mice was sufficient to eliminate an attenuated lymphocytic choriomeningitis virus (LCMV) from most tissues except for the CNS, where the virus persisted in neurons (predisposing virus). Virus-specific cytotoxic T cells (CTLs) were neither deleted nor sufficiently primed to cause disease, but they were efficiently triggered in adulthood upon WT LCMV infection (precipitating virus). This defined sequence of viral infections caused severe CNS inflammation that was histomorphologically reminiscent of rasmussen encephalitis, a fatal human autoimmune disease. Yet disease in mice was mediated by antiviral CTLs targeting an epitope shared by the precipitating virus and the predisposing virus persisting in neurons (déjà vu). Thus the concept of “viral déjà vu” demonstrates how 2 related but independently encountered viral infections can cause organ-specific immune disease without molecular mimicry of self and without breaking self tolerance.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(12)
| Title and authors |
Publication |
Year |
Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies
Sebastien E. Emonet, Shuzo Urata, Juan C. de la Torre
|
Virology
|
2011 |
Immune-mediated CNS diseases: A review on nosological classification and clinical features
Uwe K. Zettl, Olaf Stüve, Robert Patejdl
|
Autoimmunity Reviews
|
2011 |
Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child
Edwige Roy, Michele Leduc, Sarah Guegan, Latif Rachdi, Nicolas Kluger, Raphael Scharfmann, Selim Aractingi, Kiarash Khosrotehrani
|
Journal of Autoimmunity
|
2011 |
Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host
Didier Hober, Pierre Sauter
|
Nat Rev Endocrinol
|
2010 |
T cells can mediate viral clearance from ependyma but not from brain parenchyma in a major histocompatibility class I- and perforin-independent manner
D. D. Pinschewer, M. Schedensack, A. Bergthaler, E. Horvath, W. Bruck, M. Lohning, D. Merkler
|
Brain
|
2010 |
Enteroviruses and type 1 diabetes: towards a better understanding of the relationship
Hela Jaïdane, Pierre Sauter, Famara Sane, Anne Goffard, Jawhar Gharbi, Didier Hober
|
Rev. Med. Virol.
|
2010 |
Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes
D. D. Pinschewer, L. Flatz, R. Steinborn, E. Horvath, M. Fernandez, H. Lutz, M. Suter, A. Bergthaler
|
International Immunology
|
2010 |
Disease-Modifying Agents for Multiple Sclerosis
Til Menge, Martin S Weber, Bernhard Hemmer, Bernd C Kieseier, Hans-Christian von Büdingen, Clemens Warnke, Scott S Zamvil, Aaron Boster, Omar Khan, Hans-Peter Hartung, Olaf Stüve
|
Drugs
|
2008 |
Infections and Autoimmunity: A Panorama
V. Pordeus, M. Szyper-Kravitz, R. A. Levy, N. M. Vaz, Y. Shoenfeld
|
Clinic Rev Allerg Immunol
|
2008 |
Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes
H. Jaïdane, D. Hober
|
Diabetes & Metabolism
|
2008 |
|